Status:
COMPLETED
The Effect of Albumin Value, HALP Score, and LCR Value on Predicting Survival and Recurrence in Patients With Pancreatic Adenocarcinoma
Lead Sponsor:
Ege University
Conditions:
Pancreatic Neoplasms
Pancreas Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to investigate whether the albumin value and the ratios of biochemical markers; hemoglobin, albumin, lymphocyte and platelet (HALP score) and lymphocyte-C-reactive protein rat...
Eligibility Criteria
Inclusion
- Whipple operation and total pancreatectomy due to pathologically confirmed pancreatic adenocarcinoma
Exclusion
- Patients with other malignant tumors (choledochal tumor, papilla tumor and duodenal tumor)
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2023
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT06553040
Start Date
January 1 2017
End Date
January 1 2023
Last Update
August 14 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.